180 related articles for article (PubMed ID: 33427937)
1. Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan.
Tateishi R; Matsumura T; Okanoue T; Shima T; Uchino K; Fujiwara N; Senokuchi T; Kon K; Sasako T; Taniai M; Kawaguchi T; Inoue H; Watada H; Kubota N; Shimano H; Kaneko S; Hashimoto E; Watanabe S; Shiota G; Ueki K; Kashiwabara K; Matsuyama Y; Tanaka H; Kasuga M; Araki E; Koike K;
J Gastroenterol; 2021 Mar; 56(3):261-273. PubMed ID: 33427937
[TBL] [Abstract][Full Text] [Related]
2. Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic.
Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Tanaka J
J Gastroenterol Hepatol; 2017 Feb; 32(2):451-458. PubMed ID: 27288655
[TBL] [Abstract][Full Text] [Related]
3. Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China: A single-center retrospective study.
Zhu YF; Tan YF; Xu X; Zheng JL; Zhang BH; Tang HR; Yang JY
Medicine (Baltimore); 2019 Dec; 98(50):e18319. PubMed ID: 31852119
[TBL] [Abstract][Full Text] [Related]
4. Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma.
Donadon V; Balbi M; Valent F; Avogaro A
World J Gastroenterol; 2010 Jun; 16(24):3025-32. PubMed ID: 20572306
[TBL] [Abstract][Full Text] [Related]
5. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
6. Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus.
Zhang H; Gao C; Fang L; Yao SK
World J Gastroenterol; 2013 Apr; 19(15):2395-403. PubMed ID: 23613635
[TBL] [Abstract][Full Text] [Related]
7. Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.
Kawamura Y; Arase Y; Ikeda K; Seko Y; Imai N; Hosaka T; Kobayashi M; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ohmoto Y; Amakawa K; Tsuji H; Kumada H
Am J Gastroenterol; 2012 Feb; 107(2):253-61. PubMed ID: 22008893
[TBL] [Abstract][Full Text] [Related]
8. A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update.
Tateishi R; Uchino K; Fujiwara N; Takehara T; Okanoue T; Seike M; Yoshiji H; Yatsuhashi H; Shimizu M; Torimura T; Moriyama M; Sakaida I; Okada H; Chiba T; Chuma M; Nakao K; Isomoto H; Sasaki Y; Kaneko S; Masaki T; Chayama K; Koike K
J Gastroenterol; 2019 Apr; 54(4):367-376. PubMed ID: 30498904
[TBL] [Abstract][Full Text] [Related]
9. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
Ioannou GN; Green P; Kerr KF; Berry K
J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
[TBL] [Abstract][Full Text] [Related]
10. Ultrasonography screening for hepatocellular carcinoma in Japanese patients with diabetes mellitus.
Hiraoka A; Ochi M; Matsuda R; Aibiki T; Okudaira T; Kawamura T; Yamago H; Nakahara H; Suga Y; Azemoto N; Miyata H; Miyamoto Y; Ninomiya T; Hirooka M; Abe M; Matsuura B; Hiasa Y; Michitaka K
J Diabetes; 2016 Sep; 8(5):640-6. PubMed ID: 26347476
[TBL] [Abstract][Full Text] [Related]
11. Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.
Arase Y; Kobayashi M; Suzuki F; Suzuki Y; Kawamura Y; Akuta N; Kobayashi M; Sezaki H; Saito S; Hosaka T; Ikeda K; Kumada H; Kobayashi T
Hepatology; 2013 Mar; 57(3):964-73. PubMed ID: 22991257
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection.
Toyoda H; Kumada T; Tada T; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Ito T
J Gastroenterol Hepatol; 2015 Jul; 30(7):1183-9. PubMed ID: 25678094
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma in a large cohort of type 2 diabetes patients.
Giorda CB; Picariello R; Tartaglino B; Nada E; Costa G; Manti R; Monge L; Gnavi R
Diabetes Res Clin Pract; 2023 Jun; 200():110684. PubMed ID: 37100229
[TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes and hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.
Li Q; Li WW; Yang X; Fan WB; Yu JH; Xie SS; Liu L; Ma LX; Chen SJ; Kato N
Int J Cancer; 2012 Sep; 131(5):1197-202. PubMed ID: 22052244
[TBL] [Abstract][Full Text] [Related]
15. Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study.
Ide T; Koga H; Nakano M; Hashimoto S; Yatsuhashi H; Higuchi N; Nakamuta M; Oeda S; Eguchi Y; Shakado S; Sakisaka S; Yoshimaru Y; Sasaki Y; Honma Y; Harada M; Seike M; Maeshiro T; Miuma S; Nakao K; Mawatari S; Ido A; Nagata K; Matsumoto S; Takami Y; Sohda T; Kakuma T; Torimura T
Hepatol Int; 2019 May; 13(3):293-301. PubMed ID: 30820753
[TBL] [Abstract][Full Text] [Related]
16. Risk score system for the prediction of hepatocellular carcinoma in patients with type 2 diabetes: Taiwan Diabetes Study.
Li TC; Li CI; Liu CS; Lin WY; Lin CH; Yang SY; Lin CC
Semin Oncol; 2018 Oct; 45(5-6):264-274. PubMed ID: 30342872
[TBL] [Abstract][Full Text] [Related]
17. The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan.
Enomoto H; Ueno Y; Hiasa Y; Nishikawa H; Hige S; Takikawa Y; Taniai M; Ishikawa T; Yasui K; Takaki A; Takaguchi K; Ido A; Kurosaki M; Kanto T; Nishiguchi S;
J Gastroenterol; 2021 Feb; 56(2):158-167. PubMed ID: 33219410
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycemia and chronic liver diseases on risk of hepatocellular carcinoma in Chinese patients with type 2 diabetes--National cohort of Taiwan Diabetes Study.
Li CI; Chen HJ; Lai HC; Liu CS; Lin WY; Li TC; Lin CC
Int J Cancer; 2015 Jun; 136(11):2668-79. PubMed ID: 25387451
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Increased Risk of Hepatocellular Carcinoma in Patients with Type 2 Diabetes.
Si WK; Chung JW; Cho J; Baeg JY; Jang ES; Yoon H; Kim J; Shin CM; Park YS; Hwang JH; Jeong SH; Kim N; Lee DH; Lim S; Kim JW
PLoS One; 2016; 11(6):e0158066. PubMed ID: 27359325
[TBL] [Abstract][Full Text] [Related]
20. Association of type 2 diabetes mellitus with incidences of microvascular invasion and survival outcomes in hepatitis B virus-related hepatocellular carcinoma after liver resection: A multicenter study.
Zhang XP; Chai ZT; Feng JK; Zhu HM; Zhang F; Hu YR; Zhong CQ; Chen ZH; Wang K; Shi J; Guo WX; Chen CS; Wu MC; Lau WY; Cheng SQ
Eur J Surg Oncol; 2022 Jan; 48(1):142-149. PubMed ID: 34452770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]